T cells and adoptive immunotherapy: Recent developments and future prospects in gastrointestinal oncology

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Amedei, Amedeo ^a,b   Niccolai, Elena ^a   D'Elios, Mario M ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; K RAS PROTEIN; THYMIC STROMAL LYMPHOPOIETIN;

ADAPTIVE IMMUNITY; ADOPTIVE IMMUNOTHERAPY; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; COLORECTAL CANCER; DENDRITIC CELL; DIGESTIVE SYSTEM CANCER; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MICROSATELLITE INSTABILITY; NONHUMAN; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; GASTROINTESTINAL TUMOR; IMMUNOLOGY; MULTIMODALITY CANCER THERAPY; ONCOLOGY; PATHOLOGY; TRANSPLANTATION;

ANIMALS; COMBINED MODALITY THERAPY; GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MEDICAL ONCOLOGY; T-LYMPHOCYTES;

EID: 84855174106     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/320571     Document Type: Review

References (162)

1. Garcia M., Jemal A., Ward E. M., Global Cancer Facts Figures 2007. American Cancer Society, http://www.cancer.org
2. Raimondi S., Maisonneuve P., Lowenfels A. B., Epidemiology of pancreatic cancer: an overview Nature Reviews Gastroenterology and Hepatology 2009 6 12 699 708
3. American Cancer Society, Cancer Facts Figures. American Cancer Society, 2010, http://www.cancer.org/Research/CancerFactsFigures/index
4. Winter J. M., Cameron J. L., Campbell K. A., Arnold M. A., Chang D. C., Coleman J., Hodgin M. B., Sauter P. K., Hruban R. H., Riall T. S., Schulick R. D., Choti M. A., Lillemoe K. D., Yeo C. J., 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience Journal of Gastrointestinal Surgery 2006 10 9 1199 1210
5. Saka M., Morita S., Fukagawa T., Katai H., Present and future status of gastric cancer surgery Japanese Journal of Clinical Oncology 2011 41 3 307 313
6. Giuliani F., de Vita F., Colucci G., Pisconti S., Maintenance therapy in colon cancer Cancer Treatment Reviews 2010 36 supplement 3 S42 S45
7. Cunningham D., Allum W. H., Stenning S. P., Thompson J. N., van de Velde C. J. H., Nicolson M., Scarffe J. H., Lofts F. J., Falk S. J., Iveson T. J., Smith D. B., Langley R. E., Verma M., Weeden S., Yu J. C., MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer The New England Journal of Medicine 2006 355 1 11 20
8. Catenacci D. V. T., Kozloff M., Kindler H. L., Polite B., Personalized colon cancer care in 2010 Seminars in Oncology 2011 38 2 284 308
9. Artinyan A., Anaya D. A., McKenzie S., Ellenhorn J. D. I., Kim J., Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma Cancer 2011 117 10 2044 2049
10. Touchefeu Y., Harrington K. J., Galmiche J. P., Vassaux G., Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology Alimentary Pharmacology and Therapeutics 2010 32 8 953 968
11. Amedei A., Niccolai E., Bella C. D., Cianchi F., Trallori G., Benagiano M., Bencini L., Bernini M., Farsi M., Moretti R., Prete G. D., D'Elios M. M., Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma Cancer Immunology, Immunotherapy 2009 58 11 1819 1830
12. Gaudernack G., Prospects for vaccine therapy for pancreatic cancer Best Practice and Research: Clinical Gastroenterology 2006 20 2 299 314
13. Iovino F., Meraviglia S., Spina M., Orlando V., Saladino V., Dieli F., Stassi G., Todaro M., Immunotherapy targeting colon cancer stem cells Immunotherapy 2011 3 1 97 106
14. Goedert J. J., The epidemiology of acquired immunodeficiency syndrome malignancies Seminars in Oncology 2000 27 4 390 401 (Pubitemid 30626437)
15. Challis G. B., Stam H. J., The spontaneous regression of cancer. A review of cases from 1900 to 1987 Acta Oncologica 1990 29 5 545 550 (Pubitemid 20294725)
16. Zhang L., Conejo-Garcia J. R., Katsaros D., Gimotty P. A., Massobrio M., Regnani G., Makrigiannakis A., Gray H., Schlienger K., Liebman M. N., Rubin S. C., Coukos G., Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer The New England Journal of Medicine 2003 348 3 203 213 (Pubitemid 36077915)
17. Nagorsen D., Scheibenbogen C., Marincola F. M., Letsch A., Keilholz U., Natural T cell immunity against cancer Clinical Cancer Research 2003 9 12 4296 4303 (Pubitemid 37248383)
18. Erdman S. E., Poutahidis T., Roles for inflammation and regulatory T cells in colon cancer Toxicologic Pathology 2010 38 1 76 87
19. Yokokawa J., Palena C., Arlen P., Hassan R., Ho M., Pastan I., Schlom J., Tsang K. Y., Identification of novel human CTL epitopes and their agonist epitopes of mesothelin Clinical Cancer Research 2005 11 17 6342 6351 (Pubitemid 41262966)
20. Andersen M. H., Pedersen L. O., Becket J. C., Straten P. T., Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients Cancer Research 2001 61 3 869 872 (Pubitemid 32175146)
21. Johnston F. M., Tan M. C. B., Tan B. R. Jr., Porembka M. R., Brunt E. M., Linehan D. C., Simon P. O., Plambeck-Suess S., Eberlein T. J., Hellstrom K. E., Hellstrom I., Hawkins W. G., Goedegebuure P., Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer Clinical Cancer Research 2009 15 21 6511 6518
22. Kotera Y., Fontenot J. D., Pecher G., Metzgar R. S., Finn O. J., Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients Cancer Research 1994 54 11 2856 2860 (Pubitemid 24187762)
23. Kubuschok B., Neumann F., Breit R., Sester M., Schormann C., Wagner C., Sester U., Hartmann F., Wagner M., Remberger K., Schilling M., Pfreundschuh M., Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer Clinical Cancer Research 2006 12 4 1365 1372 (Pubitemid 43342530)
24. Wenandy L., Srensen R. B., Sengelv L., Svane I. M., Straten P. T., Andersen M. H., The immunogenicity of the hTERT540-548 peptide in cancer Clinical Cancer Research 2008 14 1 4 7 (Pubitemid 351377971)
25. Yanagimoto H., Mine T., Yamamoto K., Satoi S., Terakawa N., Takahashi K., Nakahara K., Honma S., Tanaka M., Mizoguchi J., Yamada A., Oka M., Kamiyama Y., Itoh K., Takai S., Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer Cancer Science 2007 98 4 605 611 (Pubitemid 46562753)
26. Kubuschok B., Xie X., Jesnowski R., Preuss K. D., Romeike B. F. M., Neumann F., Regitz E., Pistorius G., Schilling M., Scheunemann P., Izbicki J. R., Lhr J. M., Pfreundschuh M., Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis International Journal of Cancer 2004 109 4 568 575 (Pubitemid 38339648)
27. Schmitz-Winnenthal F. H., Volk C., Z'Graggen K., Galindo L., Nummer D., Ziouta Y., Bucur M., Weitz J., Schirrmacher V., Bchler M. W., Beckhove P., High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients Cancer Research 2005 65 21 10079 10087 (Pubitemid 41541490)
28. Schmitz-Winnenthal F. H., Escobedo L. V. G., Beckhove P., Schirrmacher V., Bucur M., Ziouta Y., Volk C., Schmied B., Koch M., Antolovic D., Weitz J., Bchler M. W., Z'Graggen K., Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon- International Journal of Oncology 2006 28 6 1419 1428
29. Choi C., Witzens M., Bucur M., Feuerer M., Sommerfeldt N., Trojan A., Ho A., Schirrmacher V., Goldschmidt H., Beckhove P., Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma Blood 2005 105 5 2132 2134 (Pubitemid 40731802)
30. Feuerer M., Beckhove P., Bai L., Solomayer E. F., Bastert G., Diel I. J., Pedain C., Oberniedermayr M., Schirrmacher V., Umansky V., Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow Nature Medicine 2001 7 4 452 458 (Pubitemid 32298548)
31. Mller-Berghaus J., Ehlert K., Ugurel S., Umansky V., Bucur M., Schirrmacher V., Beckhove P., Schadendorf D., Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration Cancer Research 2006 66 12 5997 6001
32. Esposito I., Menicagli M., Funel N., Bergmann F., Boggi U., Mosca F., Bevilacqua G., Campani D., Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma Journal of Clinical Pathology 2004 57 6 630 636 (Pubitemid 38725766)
33. Jesnowski R., Frst D., Ringel J., Chen Y., Schrdel A., Kleeff J., Kolb A., Schareck W. D., Lhr M., Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine Laboratory Investigation 2005 85 10 1276 1291 (Pubitemid 41348642)
34. Feuerer M., Beckhove P., Garbi N., Mahnke Y., Limmer A., Hommel M., Hmmerling G. J., Kyewski B., Hamann A., Umansky V., Schirrmacher V., Bone marrow as a priming site for T-cell responses to blood-borne antigen Nature Medicine 2003 9 9 1151 1157 (Pubitemid 37173699)
35. Fukunaga A., Miyamoto M., Cho Y., Murakami S., Kawarada Y., Oshikiri T., Kato K., Kurokawa T., Suzuoki M., Nakakubo Y., Hiraoka K., Itoh T., Morikawa T., Okushiba S., Kondo S., Katoh H., CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma Pancreas 2004 28 1 e26 e31
36. Hiraoka N., Onozato K., Kosuge T., Hirohashi S., Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clinical Cancer Research 2006 12 18 5423 5434 (Pubitemid 44497257)
37. von Bernstorff W., Voss M., Freichel S., Schmid A., Vogel I., Jhnk C., Henne-Bruns D., Kremer B., Kalthoff H., Systemic and local immunosuppression in pancreatic cancer patients Clinical Cancer Research 2001 7 3 925s 932s (Pubitemid 33600947)
38. Bernstorff W. V., Spanjaard R. A., Chan A. K., Lockhart D. C., Sadanaga N., Wood I., Peiper M., Goedegebuure P. S., Eberlein T. J., Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand Surgery 1999 125 1 73 84 (Pubitemid 29063174)
39. De Monte L., Reni M., Tassi E., Clavenna D., Papa I., Recalde H., Braga M., di Carlo V., Doglioni C., Protti M. P., Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer Journal of Experimental Medicine 2011 208 3 469 478
40. Clark C. E., Beatty G. L., Vonderheide R. H., Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer Cancer Letters 2009 279 1 1 7
41. Fong L., Small E. J., Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment Journal of Clinical Oncology 2008 26 32 5275 5283
42. Paulos C. M., June C. H., Putting the brakes on BTLA in T cell-mediated cancer immunotherapy Journal of Clinical Investigation 2010 120 1 76 80
43. Gjertsen M. K., Bakka A., Breivik J., Saeterdal I., Solheim B. G., Soreide O., Thorsby E., Gaudernack G., Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation The Lancet 1995 346 8987 1399 1400
44. Gjertsen M. K., Bjrheim J., Saeterdal I., Myklebust J., Gaudernack G., Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation International Journal of Cancer 1997 72 5 784 790 (Pubitemid 27431521)
45. Gjertsen M. K., Buanes T., Rosseland A. R., Bakka A., Gladhaug I., Sreide O., Eriksen J. A., Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: clinical and immunological responses in patients with pancreatic adenocarcinoma International Journal of Cancer 2001 92 3 441 450 (Pubitemid 32249724)
46. Hung C. F., Tsai Y. C., He L., Wu T. C., Control of mesothelin-expressing ovarian cancer using adoptive transfer of mesothelin peptide-specific CD8+ T cells Gene Therapy 2007 14 12 921 929 (Pubitemid 46865503)
47. Kawaoka T., Oka M., Takashima M., Ueno T., Yamamoto K., Yahara N., Yoshino S., Hazama S., Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1 -expressing human pancreatic cancer cell line YPK-1 Oncology Reports 2008 20 1 155 163
48. Kondo H., Hazama S., Kawaoka T., Yoshino S., Yoshida S., Tokuno K., Takashima M., Ueno T., Hinoda Y., Oka M., Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes Anticancer Research 2008 28 1 379 387 (Pubitemid 351362841)
49. Cappello P., Tomaino B., Chiarle R., Ceruti P., Novarino A., Castagnoli C., Migliorini P., Perconti G., Giallongo A., Milella M., Monsurr V., Barbi S., Scarpa A., Nistic P., Giovarelli M., Novelli F., An integrated humoral and cellular response is elicited in pancreatic cancer by -enolase, a novel pancreatic ductal adenocarcinoma-associated antigen International Journal of Cancer 2009 125 3 639 648
50. Sato N., Nabeta Y., Kondo H., Sahara H., Hirohashi Y., Kashiwagi K., Kanaseki T., Sato Y., Rong S., Hirai I., Kamiguchi K., Tamura Y., Matsuura A., Takahashi S., Torigoe T., Ikeda H., Human CD8 and CD4 T cell epitopes of epithelial cancer antigens Cancer Chemotherapy and Pharmacology 2000 46 S86 S90
51. Kondo H., Sahara H., Miyazaki A., Nabeta Y., Hirohashi Y., Kanaseki T., Yamaguchi A., Yamada N., Hirayama K., Suzuki M., Hamuro J., Torigoe T., Takahashi N., Kohama G. I., Ikeda H., Sato N., Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells Japanese Journal of Cancer Research 2002 93 8 917 924 (Pubitemid 35012254)
52. Shih N. Y., Lai H. L., Chang G. C., Lin H. C., Wu Y. C., Liu J. M., Liu K. J., Tseng S. W., Anti- -enolase autoantibodies are down-regulated in advanced cancer patients Japanese Journal of Clinical Oncology 2010 40 7 663 669
53. Tu S. H., Chang C. C., Chen C. S., Tam K. W., Wang Y. J., Lee C. H., Lin H. W., Cheng T. C., Huang C. S., Chu J. S., Shih N. Y., Chen L. C., Leu S. J., Ho Y. S., Wu C. H., Increased expression of enolase in human breast cancer confers tamoxifen resistance in human breast cancer cells Breast Cancer Research and Treatment 2010 121 3 539 553
54. Chang G. C., Liu K. J., Hsieh C. L., Hu T. S., Charoenfuprasert S., Liu H. K., Luh K. T., Hsu L. H., Wu C. W., Ting C. C., Chen C. Y., Chen K. C., Yang T. Y., Chou T. Y., Wang W. H., Whang-Peng J., Shih N. Y., Identification of -enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes Clinical Cancer Research 2006 12 19 5746 5754 (Pubitemid 44629605)
55. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 714 June 1994 IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1994 61 1 241
56. Crusius J. B. A., Canzian F., Capell G., Pea A. S., Pera G., Sala N., Agudo A., Rico F., Giudice G. D., Palli D., Plebani M., Boeing H., Bueno-de-Mesquita H. B., Carneiro F., Pala V., Save V. E., Vineis P., Tumino R., Panico S., Berglund G., Manjer J., Stenling R., Hallmans G., Martnez C., Dorronsoro M., Barricarte A., Navarro C., Quirs J. R., Allen N., Key T. J., Binghan S., Caldas C., Linseisen J., Kaaks R., Overvad K., Tjnneland A., Bchner F. C., Peeters P. H. M., Numans M. E., Clavel-Chapelon F., Trichopoulou A., Lund E., Jenab M., Rinaldi S., Ferrari P., Riboli E., Gonzlez C. A., Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST) Annals of Oncology 2008 19 11 1894 1902
57. Gonzlez C. A., Sala N., Capell G., Genetic susceptibility and gastric cancer risk International Journal of Cancer 2002 100 3 249 260 (Pubitemid 34728981)
58. Hamajima N., Naito M., Kondo T., Goto Y., Genetic factors involved in the development of Helicobacter pylori -related gastric cancer Cancer Science 2006 97 11 1129 1138 (Pubitemid 44430637)
59. Hou L., El-Omar E. M., Chen J., Grillo P., Rabkin C. S., Baccarelli A., Yeager M., Chanock S. J., Zatonski W., Sobin L. H., Lissowska J., Fraumeni J. F., Chow W. H., Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer Carcinogenesis 2007 28 1 118 123 (Pubitemid 44942634)
60. Starzyska T., Ferenc K., Wex T., Khne T., Lubiski J., Lawniczak M., Marlicz K., Malfertheiner P., The association between the interleukin-1 polymorphisms and gastric cancer risk depends on the family history of gastric carcinoma in the study population American Journal of Gastroenterology 2006 101 2 248 254 (Pubitemid 43381663)
61. Ben-Baruch A., Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators Seminars in Cancer Biology 2006 16 1 38 52 (Pubitemid 43139708)
62. Lin W. W., Karin M., A cytokine-mediated link between innate immunity, inflammation, and cancer Journal of Clinical Investigation 2007 117 5 1175 1183 (Pubitemid 46718402)
63. Kim R., Emi M., Tanabe K., Arihiro K., Tumor-driven evolution of immunosuppressive networks during malignant progression Cancer Research 2006 66 11 5527 5536 (Pubitemid 43927099)
64. Lee H. E., Chae S. W., Lee Y. J., Kim M. A., Lee H. S., Lee B. L., Kim W. H., Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer British Journal of Cancer 2008 99 10 1704 1711
65. Ren Z., Pang G., Clancy R., Li L. C., Lee C. S., Batey R., Borody T., Dunkley M., Shift of the gastric T-cell response in gastric carcinoma Journal of Gastroenterology and Hepatology 2001 16 2 142 148 (Pubitemid 32226185)
66. D'Elios M. M., Amedei A., Prete G. D., Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma Microbes and Infection 2003 5 8 723 730 (Pubitemid 36695147)
67. Maruyama T., Kono K., Mizukami Y., Kawaguchi Y., Mimura K., Watanabe M., Izawa S., Fujii H., Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer Cancer Science 2010 101 9 1947 1954
68. June C. H., Principles of adoptive T cell cancer therapy Journal of Clinical Investigation 2007 117 5 1204 1212 (Pubitemid 46718405)
69. Yee C., Thompson J. A., Byrd D., Riddell S. R., Roche P., Celis E., Greenberg P. D., Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16168 16173 (Pubitemid 35462767)
70. Kim Y. J., Lim J., Kang J. S., Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells Archives of Pharmacal Research 2010 33 11 1789 1795
71. Wu Y., Wang L., Zhang Y., Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy Cellular Molecular Immunology. 2004 1 5 351 356
72. Hoshino T., Seki N., Kikuchi M., Kuramoto T., Iwamoto O., Kodama I., Koufuji K., Takeda J., Itoh K., HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer International Journal of Cancer 1997 70 6 631 638 (Pubitemid 27158439)
73. Kono K., Rongcun Y., Charo J., Ichihara F., Celis E., Sette A., Appella E., Sekikawa T., Matsumoto Y., Kiessung R., Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific cytotoxic T lymphocytes International Journal of Cancer 1998 78 2 202 208 (Pubitemid 28443178)
74. Guo D. L., Dong M., Wang L., Sun L. P., Yuan Y., Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori-associated gastric diseases World Journal of Gastroenterology 2002 8 6 1009 1013 (Pubitemid 35446411)
75. Wu K., Nie Y., Guo C., Chen Y., Ding J., Fan D., Molecular basis of therapeutic approaches to gastric cancer Journal of Gastroenterology and Hepatology 2009 24 1 37 41
76. Nie Y., Wu K., Yang J., Tian F., Li L., Chen B., Fan D., Induction of T lymphocytes specific to human gastric cancer using HLA-A matched allogeneic gastric tumor cells Journal of Immunotherapy 2003 26 5 403 411 (Pubitemid 37128552)
77. Jiang J., Xu N., Wu C., Deng H., Lu M., Li M., Xu B., Wu J., Wang R., Xu J., Nilsson-Ehle P., Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells Anticancer Research 2006 26 3 2237 2242 (Pubitemid 43980179)
78. Wu C., Jiang J., Shi L., Xu N., Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer Anticancer Research 2008 28 6 3997 4002
79. Sun S., Li X. M., Li X. D., Yang W. S., Studies on inducing apoptosis effects and mechanism of CIK cells for MGC-803 gastric cancer cell lines Cancer Biotherapy and Radiopharmaceuticals 2005 20 2 173 180 (Pubitemid 40696099)
80. Alexander R. B., Rosenberg S. A., Long term survival of adoptively transferred tumor-infiltrating lymphocytes in mice Journal of Immunology 1990 145 5 1615 1620 (Pubitemid 20255077)
81. Kono K., Takahashi A., Ichihara F., Amemiya H., Iizuka H., Fujii H., Sekikawa T., Matsumoto Y., Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial Clinical Cancer Research 2002 8 6 1767 1771 (Pubitemid 34633733)
82. Rosenberg S. A., Yannelli J. R., Yang J. C., Topalian S. L., Schwartzentruber D. J., Weber J. S., Parkinson D. R., Seipp C. A., Einhorn J. H., White D. E., Treatment of patients with metastatic melanoma with autologous tumor- infiltrating lymphocytes and interleukin 2 Journal of the National Cancer Institute 1994 86 15 1159 1166 (Pubitemid 24249302)
83. Dudley M. E., Wunderlich J. R., Shelton T. E., Even J., Rosenberg S. A., Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients Journal of Immunotherapy 2003 26 4 332 342 (Pubitemid 36858717)
84. Tomov M., Melichar B., Sedlkov I., teiner I., Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma Gynecologic Oncology 2008 108 2 415 420 (Pubitemid 351174290)
85. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pags C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoué F., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Pags F., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 2006 313 5795 1960 1964 (Pubitemid 44498003)
86. Pags F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., Mlecnik B., Kirilovsky A., Nilsson M., Damotte D., Meatchi T., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Galon J., Effector memory T cells, early metastasis, and survival in colorectal cancer The New England Journal of Medicine 2005 353 25 2654 2666 (Pubitemid 41817714)
87. Salama P., Phillips M., Grieu F., Morris M., Zeps N., Joseph D., Platell C., Iacopetta B., Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer Journal of Clinical Oncology 2009 27 2 186 192
88. Schwitalle Y., Kloor M., Eiermann S., Linnebacher M., Kienle P., Knaebel H. P., Tariverdian M., Benner A., Doeberitz M. V. K., Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers Gastroenterology 2008 134 4 988 997 (Pubitemid 351459601)
89. Tougeron D., Fauquembergue E., Rouquette A., Le Pessot F., Sesboé R., Laurent M., Berthet P., Mauillon J., Di Fiore F., Sabourin J. C., Michel P., Tosi M., Frébourg T., Latouche J. B., Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations Modern Pathology 2009 22 9 1186 1195
90. Disis M. L., Bernhard H., Jaffee E. M., Use of tumour-responsive T cells as cancer treatment The Lancet 2009 373 9664 673 683
91. Shia J., Ellis N. A., Paty P. B., Nash G. M., Qin J., Offit K., Zhang X. M., Markowitz A. J., Nafa K., Guillem J. G., Wong W. D., Gerald W. L., Klimstra D. S., Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer American Journal of Surgical Pathology 2003 27 11 1407 1417 (Pubitemid 37315192)
92. Jenkins M. A., Hayashi S., O'Shea A. M., Burgart L. J., Smyrk T. C., Shimizu D., Waring P. M., Ruszkiewicz A. R., Pollett A. F., Redston M., Barker M. A., Baron J. A., Casey G. R., Dowty J. G., Giles G. G., Limburg P., Newcomb P., Young J. P., Walsh M. D., Thibodeau S. N., Lindor N. M., LeMarchand L., Gallinger S., Haile R. W., Potter J. D., Hopper J. L., Jass J. R., Pathology features in bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study Gastroenterology 2007 133 1 48 56 (Pubitemid 47039240)
93. Ogino S., Nosho K., Irahara N., Meyerhardt J. A., Baba Y., Shima K., Glickman J. N., Ferrone C. R., Mino-Kenudson M., Tanaka N., Dranoff G., Giovannucci E. L., Fuchs C. S., Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype Clinical Cancer Research 2009 15 20 6412 6420
94. Speetjens F. M., Lauwen M. M., Franken K. L., Janssen-van Rhijn C. M., van Duikeren S., Bres S. A., van de Velde C. J. H., Melief C. J. M., Kuppen P. J. K., van der Burg S. H., Morreau H., Offringa R., Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer International Journal of Cancer 2008 123 4 838 845 (Pubitemid 352032410)
95. Popat S., Hubner R., Houlston R. S., Systematic review of microsatellite instability and colorectal cancer prognosis Journal of Clinical Oncology 2005 23 3 609 618 (Pubitemid 46224239)
96. Ogino S., Nosho K., Kirkner G. J., Kawasaki T., Meyerhardt J. A., Loda M., Giovannucci E. L., Fuchs C. S., CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer Gut 2009 58 1 90 96
97. Samowitz W. S., Sweeney C., Herrick J., Albertsen H., Levin T. R., Murtaugh M. A., Wolff R. K., Slattery M. L., Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers Cancer Research 2005 65 14 6063 6069
98. Ogino S., Nosho K., Kirkner G. J., Shima K., Irahara N., Kure S., Chan A. T., Engelman J. A., Kraft P., Cantley L. C., Giovannucci E. L., Fuchs C. S., PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer Journal of Clinical Oncology 2009 27 9 1477 1484
99. Ogino S., Nosho K., Kirkner G. J., Kawasaki T., Chan A. T., Schernhammer E. S., Giovannucci E. L., Fuchs C. S., A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer Journal of the National Cancer Institute 2008 100 23 1734 1738
100. Nosho K., Baba Y., Tanaka N., Shima K., Hayashi M., Meyerhardt J. A., Giovannucci E., Dranoff G., Fuchs C. S., Ogino S., Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review Journal of Pathology 2010 222 4 350 366
101. Nagorsen D., Voigt S., Berg E., Stein H., Thiel E., Loddenkemper C., Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival Journal of Translational Medicine 2007 5 62
102. Yaqub S., Henjum K., Mahic M., Jahnsen F. L., Aandahl E. M., Bjrnbeth B. A., Taskén K., Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner Cancer Immunology, Immunotherapy 2008 57 6 813 821 (Pubitemid 351660125)
103. Clarke S. L., Betts G. J., Plant A., Wright K. L., El-Shanawany T. M., Harrop R., Torkington J., Rees B. I., Williams G. T., Gallimore A. M., Godkin A. J., CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer PLoS ONE 2006 1 1 e129
104. Bonertz A., Weitz J., Pietsch D. H. K., Rahbari N. N., Schlude C., Ge Y., Juenger S., Vlodavsky I., Khazaie K., Jaeger D., Reissfelder C., Antolovic D., Aigner M., Koch M., Beckhove P., Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma Journal of Clinical Investigation 2009 119 11 3311 3321
105. Bueter M., Gasser M., Schramm N., Lebedeva T., Tocco G., Gerstlauer C., Grimm M., Nichiporuk E., Thalheimer A., Thiede A., Meyer D., Benichou G., Waaga-Gasser A. M., T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma International Journal of Oncology 2006 28 2 431 438
106. Filaci G., Fenoglio D., Fravega M., Ansaldo G., Borgonovo G., Traverso P., Villaggio B., Ferrera A., Kunkl A., Rizzi M., Ferrera F., Balestra P., Ghio M., Contini P., Setti M., Olive D., Azzarone B., Carmignani G., Ravetti J. L., Torre G., Indiveri F., CD8+CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers Journal of Immunology 2007 179 7 4323 4334
107. Chaput N., Louafi S., Bardier A., Charlotte F., Vaillant J. C., FMénégaux, Rosenzwajg M., Lemoine F., Klatzmann D., Taieb J., Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue Gut 2009 58 4 520 529
108. Makita S., Kanai T., Oshima S., Uraushihara K., Totsuka T., Sawada T., Nakamura T., Koganei K., Fukushima T., Watanabe M., CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells Journal of Immunology 2004 173 5 3119 3130 (Pubitemid 39142018)
109. Yang S., Wang B., Guan C., Wu B., Cai C., Wang M., Zhang B., Liu T., Yang P., Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer Journal of Leukocyte Biology 2010 89 1 85 91
110. Rosenberg S. A., Packard B. S., Aebersold P. M., Solomon D., Topalian S. L., Toy S. T., Simon P., Lotze M. T., Yang J. C., Seipp C. A., Simpson C., Carter C., Bock S., Schwartzentruber D., Wei J. P., White D. E., Use of tumor-infiltrating lymphocyts and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report The New England Journal of Medicine 1988 319 25 1676 1680 (Pubitemid 19015247)
111. Dudley M. E., Wunderlich J. R., Robbins P. F., Cancer regression and autoimmunity in patients following clonal repopulation with anti-tumor lymphocytes Science 2002 298 5594 850 854 (Pubitemid 35231542)
112. Dudley M. E., Wunderlich J. R., Yang J. C., Sherry R. M., Topalian S. L., Restifo N. P., Royal R. E., Kammula U., White D. E., Mavroukakis S. A., Rogers L. J., Gracia G. J., Jones S. A., Mangiameli D. P., Pelletier M. M., Gea-Banacloche J., Robinson M. R., Berman D. M., Filie A. C., Abati A., Rosenberg S. A., Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma Journal of Clinical Oncology 2005 23 10 2346 2357 (Pubitemid 46218728)
113. Morgan R. A., Dudley M. E., Wunderlich J. R., Hughes M. S., Yang J. C., Sherry R. M., Royal R. E., Topalan S. L., Kammula U. S., Restifo N. P., Zheng Z., Nahvi A., de Vries C. R., Rogers-Freezer L. J., Mavroukakis S. A., Rosenberg S. A., Cancer regression in patients after transfer of genetically engineered lymphocytes Science 2006 314 5796 126 129 (Pubitemid 44547756)
114. Rosenberg S. A., Yang J. C., Restifo N. P., Cancer immunotherapy: moving beyond current vaccines Nature Medicine 2004 10 9 909 915 (Pubitemid 39273730)
115. Ossendorp F., Mengedé E., Camps M., Filius R., Melief C. J. M., Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors Journal of Experimental Medicine 1998 187 5 693 702 (Pubitemid 28115185)
116. Hung K., Hayashi R., Lafond-Walker A., Lowenstein C., Pardoll D., Levitsky H., The central role of CD4+ T cells in the antitumor immune response Journal of Experimental Medicine 1998 188 12 2357 2368 (Pubitemid 29028508)
117. Muranski P., Restifo N. P., Adoptive immunotherapy of cancer using CD4+ T cells Current Opinion in Immunology 2009 21 2 200 208
118. Ridge J. P., di Rosa F., Matzinger P., A conditioned dendritic cell can be a temporal bridge between a CD4 + T-helper and a T-killer cell Nature 1998 393 6684 474 478
119. Janssen E. M., Droin N. M., Lemmens E. E., Pinkoski M. J., Bensinger S. J., Ehst B. D., Griffith T. S., Green D. R., Schoenberger S. P., CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death Nature 2005 434 7029 88 93 (Pubitemid 40349390)
120. Bennett S. R. M., Carbone F. R., Karamalis F., Flavell R. A., Miller J. F. A. P., Heath W. R., Help for cytotoxic-T-cell responses is mediated by CD4O signalling Nature 1998 393 6684 478 480
121. Schoenberger S. P., Toes R. E. M., van der Voort E. I. H., Offringa R., Melief C. J. M., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD4OL interactions Nature 1998 393 6684 480 483
122. Rosenberg S. A., Restifo N. P., Yang J. C., Morgan R. A., Dudley M. E., Adoptive cell transfer: a clinical path to effective cancer immunotherapy Nature Reviews Cancer 2008 8 4 299 308 (Pubitemid 351430867)
123. Antony P. A., Piccirillo C. A., Akpinarli A., Finkelstein S. E., Speiss P. J., Surman D. R., Palmer D. C., Chan C. C., Klebanoff C. A., Overwijk W. W., Rosenberg S. A., Restifo N. P., CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells Journal of Immunology 2005 174 5 2591 2601 (Pubitemid 40279672)
124. Accolla R. S., Jotterand-Bellomo M., Scarpellino L., aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression Journal of Experimental Medicine 1986 164 1 369 374 (Pubitemid 16069251)
125. Steimle V., Otten L. A., Zufferey M., Mach B., Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) Cell 1993 75 1 135 146 (Pubitemid 23306027)
126. Meazza R., Comes A., Orengo A. M., Ferrini S., Accolla R. S., Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells European Journal of Immunology 2003 33 5 1183 1192 (Pubitemid 36609136)
127. Mortara L., Castellani P., Meazza R., Tosi G., Barbaro A. D. L., Procopio F. A., Comes A., Zardi L., Ferrini S., Accolla R. S., CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory Clinical Cancer Research 2006 12 11 3435 3443
128. Mortara L., Frangione V., Castellani P., Barbaro A. D. L., Accolla R. S., Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions International Immunology 2009 21 6 655 665
129. Frangione V., Mortara L., Castellani P., Barbaro A. D. L., Accolla R. S., CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy International Journal of Cancer 2010 127 7 1614 1624
130. Papailiou J., Bramis K. J., Gazouli M., Theodoropoulos G., Stem cells in colon cancer. A new era in cancer theory begins International Journal of Colorectal Disease 2011 26 1 1 11
131. Clarke M. F., Dick J. E., Dirks P. B., Eaves C. J., Jamieson C. H. M., Jones D. L., Visvader J., Weissman I. L., Wahl G. M., Cancer stem cellsperspectives on current status and future directions: AACR workshop on cancer stem cells Cancer Research 2006 66 19 9339 9344 (Pubitemid 44623625)
132. Dalerba P., Dylla S. J., Park I. K., Liu R., Wang X., Cho R. W., Hoey T., Gurney A., Huang E. H., Simeone D. M., Shelton A. A., Parmiani G., Castelli C., Clarke M. F., Phenotypic characterization of human colorectal cancer stem cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 24 10158 10163 (Pubitemid 47175279)
133. O'Brien C. A., Pollett A., Gallinger S., Dick J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 2007 445 7123 106 110 (Pubitemid 46067310)
134. Ricci-Vitiani L., Lombardi D. G., Pilozzi E., Biffoni M., Todaro M., Peschle C., de Maria R., Identification and expansion of human colon-cancer-initiating cells Nature 2007 445 7123 111 115 (Pubitemid 46067311)
135. Huang E. H., Hynes M. J., Zhang T., Ginestier C., Dontu G., Appelman H., Fields J. Z., Wicha M. S., Boman B. M., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Research 2009 69 8 3382 3389
136. Dean M., Fojo T., Bates S., Tumour stem cells and drug resistance Nature Reviews Cancer 2005 5 4 275 284 (Pubitemid 40488633)
137. Inoda S., Hirohashi Y., Torigoe T., Nakatsugawa M., Kiriyama K., Nakazawa E., Harada K., Takasu H., Tamura Y., Kamiguchi K., Asanuma H., Tsuruma T., Terui T., Ishitani K., Ohmura T., Wang Q., Greene M. I., Hasegawa T., Hirata K., Sato N., Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma Journal of Immunotherapy 2009 32 5 474 485
138. Inoda S., Morita R., Hirohashi Y., Torigoe T., Asanuma H., Nakazawa E., Nakatsugawa M., Tamura Y., Kamiguchi K., Tsuruma T., Terui T., Ishitani K., Hashino S., Wang Q., Greene M. I., Hasegawa T., Hirata K., Asaka M., Sato N., The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma Experimental and Molecular Pathology 2011 90 1 55 60
139. Naito Y., Saito K., Shiiba K., Ohuchi A., Saigenji K., Nagura H., Ohtani H., CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Research 1998 58 16 3491 3494 (Pubitemid 28376536)
140. Guidoboni M., Gaf R., Viel A., Doglioni C., Russo A., Santini A., Del Tin L., Macr E., Lanza G., Boiocchi M., Dolcetti R., Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis American Journal of Pathology 2001 159 1 297 304 (Pubitemid 33704214)
141. berg., Samii S., Stenling R., Lindmark G., Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors International Journal of Colorectal Disease 2002 17 1 25 29 (Pubitemid 41398987)
142. Petty J. K., He K., Corless C. L., Vetto J. T., Weinberg A. D., Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134) American Journal of Surgery 2002 183 5 512 518 (Pubitemid 34603419)
143. Diederichsen A. C. P., Hjelmborg J. V. B., Christensen P. B., Zeuthen J., Fenge C., Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells Cancer Immunology, Immunotherapy 2003 52 7 423 428 (Pubitemid 36831363)
144. Funada Y., Noguchi T., Kikuchi R., Takeno S., Uchida Y., Gabbert H. E., Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer Oncology Reports 2003 10 2 309 313
145. Prall F., Dhrkop T., Weirich V., Ostwald C., Lenz P., Nizze H., Barten M., Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability Human Pathology 2004 35 7 808 816 (Pubitemid 38903073)
146. Menon A. G., Janssen-Van Rhijn C. M., Morreau H., Putter H., Tollenaar R. A.E.M., van de Velde C. J. H., Fleuren G. J., Kuppen P. J. K., Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis Laboratory Investigation 2004 84 4 493 501 (Pubitemid 41656477)
147. Chiba T., Ohtani H., Mizoi T., Naito Y., Sato E., Nagura H., Ohuchi A., Ohuchi K., Shiiba K., Kurokawa Y., Satomi S., Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis British Journal of Cancer 2004 91 9 1711 1717 (Pubitemid 39546145)
148. Pags F., Berger A., Camus M., Sanchez-Cabo F., Costes A., Molidor R., Mlecnik B., Kirilovsky A., Nilsson M., Damotte D., Meatchi T., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Galon J., Effector memory T cells, early metastasis, and survival in colorectal cancer The New England Journal of Medicine 2005 353 25 2654 2666 (Pubitemid 41817714)
149. Baeten C. I. M., Castermans K., Hillen H. F. P., Griffioen A. W., Proliferating endothelial cells and leukocyte infiltration as prognostic markers in colorectal cancer Clinical Gastroenterology and Hepatology 2006 4 11 1351 1357 (Pubitemid 44716741)
150. Galon J., Costes A., Sanchez-Cabo F., Kirilovsky A., Mlecnik B., Lagorce-Pags C., Tosolini M., Camus M., Berger A., Wind P., Zinzindohoué F., Bruneval P., Cugnenc P. H., Trajanoski Z., Fridman W. H., Pags F., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 2006 313 5795 1960 1964 (Pubitemid 44498003)
151. Zlobec I., Minoo P., Baumhoer D., Baker K., Terracciano L., Jass J. R., Lugli A., Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer Cancer 2008 112 3 495 502 (Pubitemid 351186190)
152. Zlobec I., Baker K., Terracciano L., Peter S., Degen L., Beglinger C., Lugli A., Two-marker protein profile predicts poor prognosis in patients with early rectal cancer British Journal of Cancer 2008 99 10 1712 1717
153. Sinicrope F. A., Rego R. L., Ansell S. M., Knutson K. L., Foster N. R., Sargent D. J., Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma Gastroenterology 2009 137 4 1270 1279
154. Laghi L., Bianchi P., Miranda E., Balladore E., Pacetti V., Grizzi F., Allavena P., Torri V., Repici A., Santoro A., Mantovani A., Roncalli M., Malesci A., CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study The Lancet Oncology 2009 10 9 877 884
155. Frey D. M., Droeser R. A., Viehl C. T., Zlobec I., Lugli A., Zingg U., Oertli D., Kettelhack C., Terracciano L., Tornillo L., High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients International Journal of Cancer 2010 126 11 2635 2643
156. Salama P., Phillips M., Grieu F., Morris M., Zeps N., Joseph D., Platell C., Iacopetta B., Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer Journal of Clinical Oncology 2009 27 2 186 192
157. Pags F., Kirilovsky A., Mlecnik B., Asslaber M., Tosolini M., Bindea G., Lagorce C., Wind P., Marliot F., Bruneval P., Zatloukal K., Trajanoski Z., Berger A., Fridman W. H., Galon J., In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer Journal of Clinical Oncology 2009 27 35 5944 5951
158. Deschoolmeester V., Baay M., van Marck E., Weyler J., Vermeulen P., Lardon F., Vermorken J. B., Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients BMC Immunology 2010 11 19
159. Suzuki H., Chikazawa N., Tasaka T., Wada J., Yamasaki A., Kitaura Y., Sozaki M., Tanaka M., Onishi H., Morisaki T., Katano M., Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer Cancer Immunology, Immunotherapy 2010 59 5 653 661
160. Correale P., Rotundo M. S., del Vecchio M. T., Remondo C., Migali C., Ginanneschi C., Tsang K. Y., Licchetta A., Mannucci S., Loiacono L., Tassone P., Francini G., Tagliaferri P., Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy Journal of Immunotherapy 2010 33 4 435 441
161. Lee W. S., Park S., Lee W. Y., Yun S. H., Chun H. K., Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer Cancer 2010 116 22 5188 5199
162. Nosho K., Baba Y., Tanaka N., Shima K., Hayashi M., Meyerhardt J. A., Giovannucci E., Dranoff G., Fuchs C. S., Ogino S., Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review Journal of Pathology 2010 222 4 350 366